Note to dermatopathologists: When it comes to moderately atypical nevi, leave the treatment plan to clinicians - 16/05/19
Doi : 10.1016/j.jaad.2018.12.063
Thomas N. Helm, MD a, ⁎ 
, Catherine G. Chung, MD b, c, Klaus F. Helm, MD d, e
, Catherine G. Chung, MD b, c, Klaus F. Helm, MD d, e a Department of Dermatology, Buffalo Medical Group, Buffalo, New York
b Department of Dermatology, Wexner Medical Center, The Ohio State University, Columbus, Ohio
c Department of Pathology, Wexner Medical Center, The Ohio State University, Columbus, Ohio
d Department of Dermatology, Penn State Hershey Medical Center, Hershey, Pennsylvania
e Department of Pathology, Penn State Hershey Medical Center, Hershey, Pennsylvania
∗Correspondence to: Thomas N. Helm, MD, Buffalo Medical Group, Dermatopathology Laboratory, 325 Essjay Rd, Williamsville, NY 14221Buffalo Medical GroupDermatopathology Laboratory325 Essjay RdWilliamsvilleNY14221
Le texte complet de cet article est disponible en PDF.
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| Reprints not available from the authors. |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 80 - N° 6
P. e169 - juin 2019 Retour au numéro
Article précédent
- Pink or blue? Unpacking the packaging of iPLEDGE
- Jacqueline D. Watchmaker, Lauren Watchmaker, Jamie L. Abbott
- Dermoscopy in lymphoproliferative disorders—experience from a cutaneous lymphoma clinic in a tertiary cancer center
- Shamir Geller, Cristián Navarrete-Dechent, Patricia L. Myskowski
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?